India’s drug regulator has inspected nearly 90% of the country’s cough syrup manufacturers and uncovered multiple compliance lapses, according to Drugs Controller General of India Rajeev Raghuvanshi. Speaking at the 11th Global Pharmaceutical Quality Summit in Mumbai, he said strict action had been taken against serious violations. The inspections follow heightened Continue Reading
